What is Tirzepatide ?

Tirzepatide, also called a dual GLP-1/GIP agonist, is a synthetic research peptide under study in labs. It works on two key receptors: the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic polypeptide receptor (GIPR). Because it activates both, researchers use it to study metabolism and glucose control in preclinical models. Compared to single-pathway peptides, Tirzepatide targets more than one receptor, which gives scientists a broader research model.

How Does Tirzepatide Work in Research?

Tirzepatide acts on two pathways to shape metabolism:

•   GLP-1R activity – Studies focus on insulin release and glucagon control under lab conditions.
•   GIPR activity – Researchers track appetite signals and energy storage.

By activating both GLP-1R and GIPR, Tirzepatide gives a stronger model for metabolic outcomes.